DIAGNOSIS OF TUBERCULOSIS
    1.
    发明申请
    DIAGNOSIS OF TUBERCULOSIS 有权
    诊断结核病

    公开(公告)号:US20140370516A1

    公开(公告)日:2014-12-18

    申请号:US14346398

    申请日:2012-09-21

    Applicant: CSIR

    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homologous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.

    Abstract translation: 本发明包括选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6。本发明还包含选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸的互补寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6,与其至少80%同源的寡核苷酸,上述任何一个的截短部分,或上述任何一个的配对。

    Diagnosis of tuberculosis
    2.
    发明授权
    Diagnosis of tuberculosis 有权
    诊断结核病

    公开(公告)号:US09176134B2

    公开(公告)日:2015-11-03

    申请号:US14346398

    申请日:2012-09-21

    Applicant: CSIR

    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homologous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.

    Abstract translation: 本发明包括选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6。本发明还包含选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸的互补寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6,与其至少80%同源的寡核苷酸,上述任何一个的截短部分,或上述任何一个的配对。

    DIAGNOSIS OF TUBERCULOSIS
    3.
    发明申请
    DIAGNOSIS OF TUBERCULOSIS 审中-公开
    诊断结核病

    公开(公告)号:US20150260716A1

    公开(公告)日:2015-09-17

    申请号:US14725027

    申请日:2015-05-29

    Applicant: CSIR

    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homogolous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.

    Abstract translation: 本发明包括选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6。本发明还包含选自SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:3的寡核苷酸的互补寡核苷酸; SEQ ID NO:4; SEQ ID NO:5和SEQ ID NO:6,寡核苷酸与其同源至少80%,上述任何一个的截短部分,或上述任何一个的配对。

Patent Agency Ranking